|1.||Torchilin, Vladimir P: 21 articles (12/2014 - 10/2002)|
|2.||Liang, Wei: 6 articles (10/2013 - 02/2006)|
|3.||Qin, Lei: 4 articles (10/2013 - 05/2010)|
|4.||Abouzeid, Abraham H: 3 articles (10/2014 - 12/2013)|
|5.||Sarisozen, Can: 3 articles (10/2014 - 05/2012)|
|6.||Patel, Niravkumar R: 3 articles (04/2014 - 11/2012)|
|7.||Zhang, Fayun: 3 articles (10/2013 - 05/2010)|
|8.||Zhang, Chunling: 3 articles (10/2013 - 06/2011)|
|9.||Wang, Jing: 3 articles (10/2013 - 06/2011)|
|10.||Wei, Xiuli: 3 articles (10/2013 - 06/2011)|
08/04/2014 - "More importantly, FA-PEG-PE-PLA NPs@MMC-SPC presented the enhanced cell uptake/cytotoxicity in vitro and superior tumor accumulation/therapeutic efficacy in vivo while reducing the systemic toxicity. "
06/26/2012 - "This study implies PEG-PE-based drug delivery system has the potential to alter the sensitivity of cancer cells to some chemotherapeutic agents by selectively activating unfolded protein response (UPR) in cancer cells, and it also provides a useful foundation for research on ER stress-induced nanotoxicity and other lipid-based nanomaterials."
01/01/1996 - "In vitro cytotoxicity studies using RIF-1 tumor cells showed that the presence of PEG-PE, but not Gm1, significantly enhanced the cytotoxicity of liposomal NDDP. "
06/26/2012 - "In summary, we demonstrate the safety of PEG-PE in normal cells and elaborate the molecular mechanism underlying its nanotoxicity in cancer cells. "
06/26/2012 - "In addition, PEG-PE-induced ER stress also up-regulates lipid synthesis and triggers lipid droplet formation in cancer cells. "
01/01/2005 - "In vitro anticancer effects of PEG-PE/ST/LL/paclitaxel and control micelles were evaluated using human mammary adenocarcinoma (BT-20) and human ovarian carcinoma (A2780) cell lines. "
12/01/2013 - "The study was performed to evaluate the therapeutic efficacy of PEG-PE micelles, co-loaded with curcumin (CUR) and doxorubicin (DOX), and targeted with anti-GLUT1 antibody (GLUT1) against HCT-116 human colorectal adenocarcinoma cells both in vitro and in vivo. "
04/10/2014 - "The therapeutic potential of mixed micelles, made of PEG-PE and vitamin E co-loaded with curcumin and paclitaxel, was investigated against SK-OV-3 human ovarian adenocarcinoma along with its multi-drug resistant version SK-OV-3-paclitaxel-resistant (TR) cells in vitro and in vivo. "
|3.||Lewis Lung Carcinoma
08/28/2003 - "PEG-PE micelles selectively accumulated in Lewis lung carcinoma (LLC) tumors implanted in mice. "
07/01/2007 - "TPP-loaded PEG-PE micelles have been additionally modified with tumor-specific monoclonal 2C5 antibody (mAb 2C5), which resulted in significantly improved anticancer effect of the drug under the PDT conditions against murine Lewis lung carcinoma (LLC) In vivo in female C57BL/6 mice. "
|5.||Ovarian Neoplasms (Ovarian Cancer)
01/01/2010 - "The antitumor effect with PEG-PE cationic liposome encapsulated with Ad-hE (Ad-hE/lipo) was evaluated in the human ovarian cancer model. "
11/28/2012 - "We describe the evaluation of doxorubicin-loaded PEG-PE micelles targeting using an ovarian cancer cell spheroid model. "
11/28/2012 - "Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model."
01/01/2010 - "Here, we investigated antitumor effects of intravenous administration with PEG-PE cationic liposome-encapsulated recombinant human endostatin adenovirus (Ad-hEndo) on CAR-negative ovarian cancer. "
10/01/2014 - "The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors."
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Photochemotherapy (Photodynamic Therapy)
|3.||Quantum Dots (Quantum Dot)